Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innovations SummitGlobeNewsWire • 08/10/20
Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess Minimal Residual Disease (MRD) in Patients with Chronic Lymphocytic LeukemiaGlobeNewsWire • 08/06/20
Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2GlobeNewsWire • 08/04/20
Adaptive Biotechnologies Launches National Clinical Trial to Develop Novel T-Cell Based Diagnostic for Lyme DiseaseGlobeNewsWire • 07/28/20
Adaptive Biotech pushes ahead with new Seattle HQ, showing strength of life sciences industryGeekWire • 07/27/20
Adaptive Biotechnologies (ADPT) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 07/16/20
Adaptive Biotechnologies Announces Pricing of Public Offering of Common StockGlobeNewsWire • 07/15/20
Adaptive Biotechnologies to Report Second Quarter Financial Results on August 10, 2020GlobeNewsWire • 07/09/20
How Adaptive Biotechnologies (ADPT) Stock Stands Out in a Strong IndustryZacks Investment Research • 06/17/20
Adaptive Biotechnologies and Microsoft team up to track coronavirus-fighting cellsGeekWire • 06/11/20
UPDATE – Adaptive Biotechnologies to Participate in Upcoming June Investor ConferencesGlobeNewsWire • 06/08/20
5 Biotech Stocks in Focus as Race for Coronavirus Vaccine Heats UpZacks Investment Research • 05/19/20
Inside the quest for a new COVID-19 test: Microsoft, Adaptive Biotech and the hidden power of immunityGeekWire • 05/15/20
Adaptive Biotechnologies Corporation (ADPT) CEO Chad Robins on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/13/20
Adaptive Biotech revenue rises 65% to $21M, loss widens amid big COVID-19 immune partnershipsGeekWire • 05/12/20
Adaptive Biotechnologies and Microsoft Announce New Study of COVID-19 Immune ResponseThe Motley Fool • 05/06/20
Microsoft and Adaptive launch quest for new COVID-19 test, seeking 1k people for immune studyGeekWire • 05/05/20